2020
Resected Pancreatic Cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant Chemotherapy
Liu C, Cheng H, Jin K, Fan Z, Gong Y, Qian Y, Deng S, Huang Q, Ni Q, Yu X, Luo G. Resected Pancreatic Cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant Chemotherapy. Cancer Control 2020, 27: 1073274820915947. PMID: 32268796, PMCID: PMC7153189, DOI: 10.1177/1073274820915947.Peer-Reviewed Original ResearchConceptsGemcitabine-based adjuvant chemotherapyResectable pancreatic cancerPancreatic cancerAdjuvant chemotherapyN2 node involvementNode involvementCurative resection of pancreatic adenocarcinomaResection of pancreatic adenocarcinomaGemcitabine-based regimenGemcitabine-based treatmentNode-positive subgroupEfficacy of gemcitabineGemcitabine-based chemotherapyN2 tumorsAdjuvant regimenNodal involvementNodal statusNode-negativeCurative resectionPancreatic adenocarcinomaSubgroup patientsLymphatic metastasisChemotherapyPatientsCancer
2017
Hepatocellular Carcinoma Metastasis and Circulating Tumor Cells
Pham K, Delitto D, Liu C. Hepatocellular Carcinoma Metastasis and Circulating Tumor Cells. Molecular Pathology Library 2017, 153-173. DOI: 10.1007/978-3-319-68082-8_9.Peer-Reviewed Original ResearchHepatocellular carcinomaExtent of diseaseCancer cellsAggressive hepatocellular carcinomaHepatocellular carcinoma metastasisCirculating Tumor CellsCurative resectionSystemic treatmentMetastatic lesionsCarcinoma metastasisHCC microenvironmentSecondary tumorsDifferent malignanciesClinical practiceHost stromaHepatic microenvironmentPrimary siteHCC metastasisMetastasisMetastatic processCancer disseminationTumor cellsMetastatic cellsDistant sitesPhysiologic complexity